Human Epidermal Neural Crest Stem Cells as Candidates for Cell-Based Therapies, Disease Modeling, and Drug Discovery

被引:12
|
作者
Sieber-Blum, Maya [1 ]
机构
[1] Newcastle Univ, Inst Med Genet, Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
基金
英国医学研究理事会;
关键词
hEPI-NCSC; EPI-NCSC; neural crest; dopaminergic neuron; Schwann cells; Parkinson's disease; peripheral neuropathy; spinal cord injury; INVITRO CLONAL ANALYSIS; SPINAL-CORD-INJURY; HAIR FOLLICLE; EPI-NCSC; QUAIL EMBRYO; PLURIPOTENT; PROGENITOR; DIFFERENTIATION; LOCATION; BULGE;
D O I
10.1002/bdrc.21073
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this review article I explore the suitability of human epidermal neural crest stem cells (hEPI-NCSC) for translational medicine. hEPI-NCSC are multipotent somatic stem cells that are derived from the embryonic neural crest. hEPI-NCSC are located in the bulge of hair follicles where they persist postnatally and into adulthood. Because of their location in the hairy skin and their migratory behavior, hEPI-NCSC can be easily isolated as a highly pure population of stem cells without the need for purification. Furthermore they can be expanded ex vivo into millions of stem cells, they do not form tumors in vivo, and they can undergo directed differentiation into crest and noncrest-derived cell types of clinical relevance. Taken together, these characteristics make hEPI-NCSC attractive candidates for cell-based therapies, drug discovery, and disease modeling. Birth Defects Research (Part C) 102:221-226, 2014. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:221 / 226
页数:6
相关论文
共 50 条
  • [21] Prospects for neural stem cell-based therapies for neurological diseases
    Imitola, Jaime
    NEUROTHERAPEUTICS, 2007, 4 (04) : 701 - 714
  • [22] Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization
    Profico, Daniela Celeste
    Gelati, Maurizio
    Ferrari, Daniela
    Sgaravizzi, Giada
    Ricciolini, Claudia
    Pensi, Massimo Projetti
    Muzi, Gianmarco
    Cajola, Laura
    Copetti, Massimiliano
    Ciusani, Emilio
    Pugliese, Raffaele
    Gelain, Fabrizio
    Vescovi, Angelo Luigi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [23] Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease
    Inak, Gizem
    Lorenz, Carmen
    Lisowski, Pawel
    Zink, Annika
    Mlody, Barbara
    Prigione, Alessandro
    STEM CELLS, 2017, 35 (07) : 1655 - 1662
  • [24] Stem Cell-Based Disease Modeling and Cell Therapy
    Bai, Xiaowen
    CELLS, 2020, 9 (10)
  • [25] Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders
    Benchoua, Alexandra
    Lasbareilles, Marie
    Tournois, Johana
    CELLS, 2021, 10 (12)
  • [26] Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing
    Shaheen, N.
    Shiti, A.
    Gepstein, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (02) : 203 - 208
  • [27] Drug discovery through stem cell-based organoid models
    Ranga, Adrian
    Gjorevski, Nikolche
    Lutolf, Matthias P.
    ADVANCED DRUG DELIVERY REVIEWS, 2014, 69 : 19 - 28
  • [28] Modeling Ewing sarcoma initiation in human neural crest stem cells
    von Levetzow, Cornelia
    von Levetzow, Gregor
    Hsu, Jessie H.
    Cole, Ron
    Brena, Romulo Martin
    Laird, Peter W.
    Lawlor, Elizabeth R.
    CANCER RESEARCH, 2011, 71
  • [29] Modeling brain and neural crest neoplasms with human pluripotent stem cells
    Schloo, Cedar
    Kutscher, Lena M.
    NEURO-ONCOLOGY, 2023, 25 (07) : 1225 - 1235
  • [30] Modeling the initiation of Ewing sarcoma in human neural crest stem cells
    von Levetzow, Cornelia
    von Levetzow, Gregor
    Hsu, Jessie H.
    Brena, Romulo Martin
    Laird, Peter W.
    Lawlor, Elizabeth R.
    CANCER RESEARCH, 2011, 71